Cargando…
The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645562/ http://dx.doi.org/10.1186/2051-1426-3-S2-P168 |
| _version_ | 1782400840719400960 |
|---|---|
| author | Regan, Courtney Nishimura, Michael Le Poole, I Caroline Godellas, Constantine Stiff, Patrick Garrett-Mayer, Elizabeth Li, Mingli Shirai, Keisuke Eby, Jonathan Embree, Heather Dropulic, Boro Clark, Ann Lau Hutchens, Kelli Clark, Joseph I |
| author_facet | Regan, Courtney Nishimura, Michael Le Poole, I Caroline Godellas, Constantine Stiff, Patrick Garrett-Mayer, Elizabeth Li, Mingli Shirai, Keisuke Eby, Jonathan Embree, Heather Dropulic, Boro Clark, Ann Lau Hutchens, Kelli Clark, Joseph I |
| author_sort | Regan, Courtney |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455622015-11-20 The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study Regan, Courtney Nishimura, Michael Le Poole, I Caroline Godellas, Constantine Stiff, Patrick Garrett-Mayer, Elizabeth Li, Mingli Shirai, Keisuke Eby, Jonathan Embree, Heather Dropulic, Boro Clark, Ann Lau Hutchens, Kelli Clark, Joseph I J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645562/ http://dx.doi.org/10.1186/2051-1426-3-S2-P168 Text en Copyright © 2015 Regan et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Regan, Courtney Nishimura, Michael Le Poole, I Caroline Godellas, Constantine Stiff, Patrick Garrett-Mayer, Elizabeth Li, Mingli Shirai, Keisuke Eby, Jonathan Embree, Heather Dropulic, Boro Clark, Ann Lau Hutchens, Kelli Clark, Joseph I The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title | The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title_full | The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title_fullStr | The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title_full_unstemmed | The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title_short | The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study |
| title_sort | transfer of genetically engineered lymphocytes in melanoma patients: a phase i dose escalation study |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645562/ http://dx.doi.org/10.1186/2051-1426-3-S2-P168 |
| work_keys_str_mv | AT regancourtney thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT nishimuramichael thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT lepooleicaroline thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT godellasconstantine thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT stiffpatrick thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT garrettmayerelizabeth thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT limingli thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT shiraikeisuke thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT ebyjonathan thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT embreeheather thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT dropulicboro thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT clarkannlau thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT hutchenskelli thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT clarkjosephi thetransferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT regancourtney transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT nishimuramichael transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT lepooleicaroline transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT godellasconstantine transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT stiffpatrick transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT garrettmayerelizabeth transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT limingli transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT shiraikeisuke transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT ebyjonathan transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT embreeheather transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT dropulicboro transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT clarkannlau transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT hutchenskelli transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy AT clarkjosephi transferofgeneticallyengineeredlymphocytesinmelanomapatientsaphaseidoseescalationstudy |